Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ADR Biomedical HoldingsTSE:3750 -0.37%30 Days Inventory is 414.24 as of Mar. 2026, which is 45% below its 10-year median of 753.51. GuruFocus rates TSE:3750 with a GF Score™ of 30/100 and a GF Value™ of 円40.31 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 638 Biotechnology companies, ADR Biomedical Holdings ranks worse than 83.39% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
ADR Biomedical Holdings's Inventory Turnover for the
six
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ADR Biomedical Holdings's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 1.97.
ADR Biomedical Holdings (TSE:3750) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ADR Biomedical Holdings's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ADR Biomedical Holdings's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ADR Biomedical Holdings Days Inventory Related Terms
ADR Biomedical Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3750 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, ADR Biomedical Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ADR Biomedical Holdings Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ADR Biomedical Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where ADR Biomedical Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADR Biomedical Holdings (TSE:3750) has a Days Inventory of 414.24 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ADR Biomedical Holdings and its competitors. This is 45% below median its historical median of 753.51. Over the past decade, ADR Biomedical Holdings' Days Inventory has ranged from 60.50 to 4,682.30. According to the industry distribution chart, ADR Biomedical Holdings ranks #532 out of 638 companies in the Biotechnology industry, placing it in the top 83.4%.
Is ADR Biomedical Holdings' Days Inventory too high?
ADR Biomedical Holdings' current Days Inventory of 414.24 is 45% below median its 10-year median of 753.51. Over the past 10 years, this metric has ranged from a low of 60.50 to a high of 4,682.30. The Biotechnology industry median Days Inventory is 183.20. ADR Biomedical Holdings' value of 414.24 is 126.1% above this industry median. Based on the distribution chart, ADR Biomedical Holdings ranks #532 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ADR Biomedical Holdings has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR Biomedical Holdings' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ADR Biomedical Holdings ranks #532 out of 638 companies for Days Inventory. This places ADR Biomedical Holdings in the lower half of its industry. The industry median Days Inventory is 183.20. ADR Biomedical Holdings' value of 414.24 is 126.1% above this benchmark. Historically, ADR Biomedical Holdings' own Days Inventory has ranged from 60.50 to 4,682.30 over the past decade. While the company's 10-year median is 753.51 vs. the industry median of 183.20, ADR Biomedical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ADR Biomedical Holdings's current Days Inventory of 414.24 is 126.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ADR Biomedical Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ADR Biomedical Holdings's current Days Inventory is 414.24, which is 45% below median its own 10-year median of 753.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR Biomedical Holdings stock overvalued right now?
Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円40.31, compared to a current price of 円805.00 — trading 1897% above its estimated fair value. The current Days Inventory is 414.24, which is 45% below median its 10-year median of 753.51 and 126.1% above the Biotechnology industry median of 183.20. ADR Biomedical Holdings' overall GF Score™ is 30/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current Days Inventory is 414.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?
Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued.
The current stock price of 円805.00 is trading 1897% above its estimated GF Value™ of 円40.31.
GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.
Key valuation signals for TSE:3750:
Days Inventory: 414.24 (45% below median its 10-year median of 753.51)
GF Value™: 円40.31 vs. price of 円805.00 (1897% above fair value)
Industry Position: 126.1% above the Biotechnology median (#532 of 638)
No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
30GF Score
Get the complete analysis for TSE:3750
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3750 has been successfully added to your 
